<DOC>
	<DOCNO>NCT02798705</DOCNO>
	<brief_summary>The aim study evaluate coronary flow reserve ( CFR ) , index microcirculatory resistance ( IMR ) , proportion overt microvascular disease , define depressed CFR well elevate IMR patient cardiac amyloidosis . The second objective study compare result non-invasive test include serum light chain amount , Doppler echocardiography 2D strain , cardiac perfusion MRI .</brief_summary>
	<brief_title>Physiologic Assessment Microvascular Function Patients With Cardiac Amyloidosis</brief_title>
	<detailed_description>Amyloidosis rare systemic disorder characterize extracellular deposition misfolded protein various organ system , include heart . Among several type amyloid fibril , light chain transthyretin amyloid proteins commonly affect heart . Cardiac amyloid deposit result increase ventricular wall thickness produce restrictive cardiomyopathy present primarily biventricular congestive heart failure . Anginal symptom sign ischemia report patient cardiac amyloidosis without obstructive epicardial coronary artery disease ( CAD ) . Autopsy study show amyloid deposit around cardiac myocytes interstitium , perivascular region , medium intramyocardial coronary vessel . Amyloidosis thus prime example disorder potential cause coronary microvascular dysfunction via 3 major mechanism : ( 1 ) structural ( amyloid deposition vessel wall cause wall thicken luminal stenosis ) , ( 2 ) extravascular ( extrinsic compression microvasculature perivascular interstitial amyloid deposit decrease diastolic perfusion ) , ( 3 ) functional ( autonomic endothelial dysfunction ) . Previous basic research present adipose arteriole atrial coronary arteriole show endothelial dysfunction even brief exposure physiologic amount light chain , also show increase oxidative stress , reduce NO bioavailability , peroxynitrite production . All previous evidence imply coronary microvascular dysfunction subsequent global ischemic insult precursor overt diastolic systolic dysfunction patient cardiac amyloidosis . However , 1 study evaluate microvascular function vivo use N13-ammonium positron emission tomography ( PET ) . In study , Dorbala et al . demonstrated amyloidosis patient show depressed global rest myocardial blood flow ( MBF ) , stress MBF , CFR high minimal coronary vascular resistance , compare patient leave ventricular hypertrophy . However , low availability , high cost , limited resolution N13 ammonium PET preclude generalizability result . Since thermodilution-derived coronary flow reserve index microcirculatory reserve use pressure-temperature wire well validate prognostic index assessment patient coronary artery disease functionally insignificant epicardial coronary stenosis , invasive physiologic assessment might specifically assess macro- microvascular function patient cardiac amyloidosis . Moreover , add physiologic measurement current frame diagnosis cardiac amyloidosis might enhance risk stratification patient . Therefore , current study perform physiologic assessment include fractional flow reserve , coronary flow reserve , index microcirculatory resistance patient cardiac amyloidosis , explore correlation among physiologic index conventional measurement echocardiography , perfusion MRI , serum light chain amount , NT-proBNP . In addition , difference physiologic index accord disease severity cardiac amyloidosis , measure endomyocardial biopsy finding also explore . Since previous study perform invasive physiologic assessment amyloidosis patient , study perform pilot study . Target sample size 30 patient .</detailed_description>
	<mesh_term>Amyloidosis</mesh_term>
	<criteria>Subject age 1885 year old Patients confirm cardiac amyloidosis heart biopsy Patients confirm amyloidosis biopsy heart evidence cardiac involvement echocardiography Patients cardiogenic shock Patients unstable vital sign precludes coronary angiography Patients major bleed last 3 month Patients active bleeding Patients coagulopathy Patients severe valvular heart disease Patients refuse provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Cardiac amyloidosis</keyword>
	<keyword>Fractional flow reserve</keyword>
	<keyword>Microvascular dysfunction</keyword>
	<keyword>Coronary flow reserve</keyword>
	<keyword>Index microcirculatory resistance</keyword>
</DOC>